Preeya Gupta, MD
Show Description +
Preeya Gupta, MD, reviews what stands out to her the most about Qlosi (pilocarpine HCL ophthalmic solution 0.4%, Orasis Pharmaceuticals), a novel therapy to target presbyopia. She describes the benefits of its formulation and patient selection for getting started with this pharmacologic treatment.
Posted: 5/08/2025
Preeya Gupta, MD
Preeya Gupta, MD, reviews what stands out to her the most about Qlosi (pilocarpine HCL ophthalmic solution 0.4%, Orasis Pharmaceuticals), a novel therapy to target presbyopia. She describes the benefits of its formulation and patient selection for getting started with this pharmacologic treatment.
Posted: 5/08/2025
About Orasis Pharmaceuticals
ORASIS (OR-uh-sis) Pharmaceuticals is an emerging ophthalmic pharmaceutical company, with offices in the US and Israel, focused on developing an innovative solution for the treatment of presbyopia symptoms. Orasis’ novel proprietary formulation of low dose pilocarpine and a proprietary vehicle was purposefully designed with the patient in mind to achieve an optimal balance among efficacy, safety, and comfort.
The name Orasis has its roots in the Greek language, where it carries a literal translation of “good vision or sight.” Beyond this, however, as good vision in its positive mental/philosophical meaning — and this speaks to our aspiration as a company to develop pharmaceutical drugs that improve vision and quality of life for millions of people around the world.
Visit us online: orasis-pharma.com
Follow Orasis Pharmaceuticals